Curewell invests growth equity in WeInfuse

WeInfuse announced growth equity from Curewell to expand its infusion-therapy software platform and related offerings. Curewell partners Michael Dal Bello and Ceron Rhee, alongside senior advisor George Lazenby, joined the board. The companies also formed an infusion-technology advisory council. Terms were not disclosed.